company background image
BVF logo

Bausch Health Companies DB:BVF Stock Report

Last Price

€4.10

Market Cap

€1.5b

7D

0%

1Y

-36.2%

Updated

16 May, 2025

Data

Company Financials +

Bausch Health Companies Inc.

DB:BVF Stock Report

Market Cap: €1.5b

BVF Stock Overview

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. More details

BVF fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Rewards

Trading at 93.1% below our estimate of its fair value

Earnings are forecast to grow 112.54% per year

Earnings have grown 44.1% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Negative shareholders equity


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Bausch Health Companies Inc. Competitors

Dermapharm Holding

XTRA:DMP

€1.9b

PharmaSGP Holding

XTRA:PSG

€308.5m

Bayer

XTRA:BAYN

€22.5b

Apontis Pharma

XTRA:APPH

€93.7m

Price History & Performance

Summary of share price highs, lows and changes for Bausch Health Companies
Historical stock prices
Current Share PriceUS$4.10
52 Week HighUS$8.90
52 Week LowUS$4.11
Beta0.34
1 Month Change-13.52%
3 Month Change-34.36%
1 Year Change-36.25%
3 Year Change-55.97%
5 Year Change-75.18%
Change since IPO-54.60%

Recent News & Updates

Recent updates

Shareholder Returns

BVFDE PharmaceuticalsDE Market
7D0%-4.1%1.2%
1Y-36.2%-27.8%14.0%

Return vs Industry: BVF underperformed the German Pharmaceuticals industry which returned -27.8% over the past year.

Return vs Market: BVF underperformed the German Market which returned 14% over the past year.

Price Volatility

Is BVF's price volatile compared to industry and market?
BVF volatility
BVF Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.4%
10% most volatile stocks in DE Market13.0%
10% least volatile stocks in DE Market3.1%

Stable Share Price: BVF's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine BVF's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a20,700Tom Appiowww.bauschhealth.com

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products.

Bausch Health Companies Inc. Fundamentals Summary

How do Bausch Health Companies's earnings and revenue compare to its market cap?
BVF fundamental statistics
Market cap€1.53b
Earnings (TTM)-€35.89m
Revenue (TTM)€8.73b

0.2x

P/S Ratio

-42.5x

P/E Ratio

Is BVF overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BVF income statement (TTM)
RevenueUS$9.73b
Cost of RevenueUS$2.84b
Gross ProfitUS$6.89b
Other ExpensesUS$6.93b
Earnings-US$40.00m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin70.78%
Net Profit Margin-0.41%
Debt/Equity Ratio-8,962.5%

How did BVF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 19:47
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bausch Health Companies Inc. is covered by 39 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas TsaoBarclays
Ardalan ArfaeiBMO Capital Markets Equity Research
Robert HazlettBMO Capital Markets U.S. (Historical)